Keywords: آنتی بادی درمان; Carotid disease; Carotid stenosis; Atherosclerotic disease; Stroke; Carotid endarterectomy; Carotid angioplasty and stenting; Antiplatelet therapy;
مقالات ISI آنتی بادی درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی درمان; Antiplatelet therapy; clopidogrel; drug metabolism; genetic testing; stroke; transient ischemic attack;
Keywords: آنتی بادی درمان; Non cardiac surgery; Bleeding; Stent thrombosis; Antiplatelet therapy; Heparin-bridge
Keywords: آنتی بادی درمان; Antiplatelet therapy; aspirin; fibrates; fibrinolytics; hyperlipidaemia; lipid disorders; nicotinic acid; omega-3 fatty acids; statins
Keywords: آنتی بادی درمان; Coronary artery disease; Bleeding; Drug eluting stents; Diabetes mellitus; Antiplatelet therapy
Keywords: آنتی بادی درمان; Tratamiento antiagregante; SÃndrome coronario agudo; Intervencionismo coronario percutáneo; Antiplatelet therapy; Acute coronary syndrome; Percutaneous coronary intervention;
Keywords: آنتی بادی درمان; Intracranial aneurysm; stent-assisted coil embolization; ischemic event; antiplatelet therapy
Keywords: آنتی بادی درمان; 16; 23; 38; ADP; adenosine diphosphate; APT; antiplatelet therapy; BOCLA-Plan; BOchum CLopidogrel and Aspirin Plan; CABG; coronary artery bypass grafting; CI; confidence interval; CYP; cytochrome P450; dAPT; dual antiplatelet therapy; HR; hazard ratio; hR
Keywords: آنتی بادی درمان; antiplatelet therapy; clinical outcomes; Immature platelets; residual platelet reactivityAUC, area under the curve; CAD, coronary artery disease; IPC, immature platelet count; IPF, immature platelet fraction; MACE, major adverse cardiovascular event(s); N
Keywords: آنتی بادی درمان; Laparoscopy; Endometrial cancer; Aspirin; Antiplatelet therapy; Lymphadenectomy;
Keywords: آنتی بادی درمان; Postoperative atrial fibrillation; Anticoagulation; Antiplatelet therapy; Rate control; Risk factors;
Keywords: آنتی بادی درمان; Malignancy; Cardiovascular disease; Anticoagulants; Antiplatelet therapy; Endoscopic screening;
Keywords: آنتی بادی درمان; Cerebral aneurisms; Endovascular treatment; Complications; Anticoagulation; Antiplatelet therapy; Thrombo-embolism;
Keywords: آنتی بادی درمان; Antithrombotic therapy; Antiplatelet therapy; Valve surgery;
Keywords: آنتی بادی درمان; APT; antiplatelet therapy; cAPT; noninterrupted antiplatelet therapy; CDC; Clavien-Dindo classification; DES; drug-eluting stent; iAPT; interrupted antiplatelet therapy; NYHA; New York Heart Association; OR; odds ratio; PCI; percutaneous coronary interven
Keywords: آنتی بادی درمان; AMP-activated protein kinase (AMPK); Platelet aggregation; Antiplatelet therapy; Thrombosis 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR);
Keywords: آنتی بادی درمان; Acute stroke; Catheter-based thrombectomy; Thrombolysis; Anticoagulation; Antiplatelet therapy; Heparin; Aspirin; Fibrinolysis
Pharmacogenomic Testing to Select Antiplatelet Therapyâ
Keywords: آنتی بادی درمان; acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor;
Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process
Keywords: آنتی بادی درمان; Antiplatelet therapy; ADP; P2Y12 antagonists; HTS; Parallel synthesis;
Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review
Keywords: آنتی بادی درمان; Assist device; Thrombosis; Bleeding; Antiplatelet therapy; Anticoagulation; Antithrombotic management;
Complicaciones trombóticas y hemorrágicas en pacientes con aneurismas cerebrales tratados por vÃa endovascular y su relación con el uso de antiagregantes plaquetarios: evaluación descriptiva
Keywords: آنتی بادی درمان; Tratamiento antiplaquetario; Aneurismas cerebrales; Tratamiento endovascular; Hemorragia intracerebral; Infarto cerebral; Antiplatelet therapy; Cerebral aneurysm; Endovascular treatment; Intracerebral haemorrhage; Cerebral infarction;
Ischaemic heart disease: management of non-ST elevation acute coronary syndrome
Keywords: آنتی بادی درمان; Acute coronary syndrome; anticoagulant; antiplatelet therapy; coronary angiography; coronary artery bypass surgery; MRCP; myocardial infarction; percutaneous coronary intervention; unstable angina;
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the Fr
Keywords: آنتی بادی درمان; Antiplatelet therapy; Surgery; Haemorrhage; Thrombosis; Local anaesthesia; Agent antiplaquettaire; Chirurgie; Hémorragie; Thrombose; Anesthésie loco-régionale; ADP; adenosine diphosphate; CABG; coronary artery bypass graft; DAPT; dual antiplatelet ther
The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
Keywords: آنتی بادی درمان; ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; CABG; Coronary artery bypass grafting; STEMI; ST-segment elevation myocardial infarction; NSTEMI; Non-ST-segment elevation myocardial infarction; MI; Myocardial infarction; CV; Cardiov
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
Keywords: آنتی بادی درمان; ACS; acute coronary syndrome; ACCOAST trial; Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time of Diagnosis in Patients with Non-ST Elevation Myocardial Infarction trial; ACUITY; acute catheterization
Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement
Keywords: آنتی بادی درمان; anticoagulant therapy; antiplatelet therapy; antithrombotic therapy; TAVR;
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study
Keywords: آنتی بادی درمان; Antiplatelet therapy; Myocardial infarction;
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention
Keywords: آنتی بادی درمان; aspirin; platelet aggregation; platelet function tests; P2Y12 receptor antagonists; stent thrombosis; ADP; adenosine diphosphate; APT; antiplatelet therapy; ARU; aspirin reaction unit; HPR; high platelet reactivity; HPR-AA; high platelet reactivity on asp
Review ArticleFlow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review
Keywords: آنتی بادی درمان; APT; antiplatelet; ASA; aspirin; PED; Pipeline Embolization Device; Antiplatelet therapy; Aspirin; Intracranial aneurysms; Flow diverter; Pipeline embolization device;
Protocolo de consenso en el tratamiento antitrombótico (anticoagulación y antiagregación) durante el periodo perioperatorio y periprocedimiento en neurocirugÃa
Keywords: آنتی بادی درمان; Tratamiento antitrombótico; Anticoagulantes; Antiagregantes; Riesgo hemorragico; Perioperatorio; Neurocirugia; Antithrombotic treatment; Anticoagulant therapy; Antiplatelet therapy; Haemorrhage risk; Perioperative; Neurosurgery;
Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary Intervention
Keywords: آنتی بادی درمان; Antiplatelet therapy; Coronary artery disease; Protease-activated receptors; Vorapaxar; Myocardial infarction; Percutaneous coronary intervention;
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Keywords: آنتی بادی درمان; antiplatelet therapy; bleeding; coronary artery disease; outcomes; CHAMPION; Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition; CI; confidence interval; GPI; glycoprotein IIb/IIIa inhibitor; GUSTO; Global Use of Strate
Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients
Keywords: آنتی بادی درمان; antiplatelet therapy; antithrombotic therapy; bare-metal coronary stent(s); bleeding; chronic anticoagulation; drug-coated coronary stent(s); percutaneous coronary intervention; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DCS; drug-coated s
REVIEWStirred, shaken, or stagnant: What goes on at the blood-biomaterial interface
Keywords: آنتی بادی درمان; Hemocompatibility; Cardiovascular implants; Biomaterials; Platelets; Coagulation; Antiplatelet therapy;
SÃndrome coronario agudo sin elevación del segmento ST
Keywords: آنتی بادی درمان; Dolor torácico; Elevación de troponina; Alteraciones de repolarización; Antiagregación; Chest pain; Antiplatelet therapy; Cardiac troponin; Abnormal repolarization;
Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS
Keywords: آنتی بادی درمان; antiplatelet therapy; bleeding; percutaneous coronary intervention; quality of life; ADP; adenosine diphosphate; AMI; acute myocardial infarction; BARC; Bleeding Academic Research Consortium; DAPT; dual antiplatelet therapy; DCRI; Duke Clinical Research I
Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry
Keywords: آنتی بادی درمان; Acute myocardial infarction; Antiplatelet therapy; Coronary artery disease; Reperfusion therapy; ST-elevation myocardial infarction;
Current status of data on cangrelor
Keywords: آنتی بادی درمان; Acute coronary syndrome; Antiplatelet therapy; Cangrelor; Coronary artery disease; P2Y12 receptor inhibition; Percutaneous coronary intervention (PCI)ACS, Acute Coronary Syndromes; ACUITY, Acute Catheterization and Urgent Intervention Triage Strategy; ARC
Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis
Keywords: آنتی بادی درمان; Ischemic stroke; ozagrel; propensity score matching; Diagnosis Procedure Combination database; antiplatelet therapy; stroke recurrence;
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Keywords: آنتی بادی درمان; bleeding; stroke; transcatheter aortic valve replacement; warfarin; AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CAD; coronary artery disease; CI; confidence interval; DT; double therapy; HR; hazard rati
New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors
Keywords: آنتی بادی درمان; Antiplatelet therapy; Antithrombotics; Adenosine diphosphate; Cardiovascular disease; Acute coronary syndromes; P2Y1; P2Y12; P2X1; Dinucleoside polyphosphates; Bis-nucleoside polyphosphates; Inhibitors; PlateletsAp4A, P1,P4-di(adenosine-5′) tetraphosphate
Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility
Keywords: آنتی بادی درمان; antiplatelet therapy; acute coronary syndrome; primary PCI; ST elevation myocardial infarction; ticagrelor;
Prasugrel inhibits platelet-enhanced pro-inflammatory CD4+ T cell responses in humans
Keywords: آنتی بادی درمان; Platelets; Inflammation; Atherosclerosis; Antiplatelet therapy;
Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry
Keywords: آنتی بادی درمان; Stents; Antiplatelet therapy; Thrombosis; Coronary artery disease;
Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
Keywords: آنتی بادی درمان; Antiplatelet therapy; Ticagrelor; Intracranial hemorrhage; Subdural hematoma; Acute coronary syndrome
Use, efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice. Results of the prospective ATACS-registry
Keywords: آنتی بادی درمان; Percutaneous coronary intervention; ST elevation myocardial infarction; Antiplatelet therapy; Prasugrel; Clopidogrel;
Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registry
Keywords: آنتی بادی درمان; Antiplatelet therapy; Mortality; Clopidogrel; Aspirin;
Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina
Keywords: آنتی بادی درمان; CYP2C19; Antiplatelet therapy; Clopidogrel; Polymorphism; Percutaneous coronary intervention;
Thrombotic Complications Associated With Early and Late Nonadherence to Dual Antiplatelet Therapy
Keywords: آنتی بادی درمان; antiplatelet therapy; stent; thrombosis; ANA; any nonadherence; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; E-ZES; Endeavor zotarolimus-eluting stent; MI; myocardial infarction;
Terapia antiplaquetaria doble de 6 o de 12 meses tras implante de stents farmacoactivos de nueva generación: análisis emparejado de los registros ESTROFA-DAPT y ESTROFA-2
Keywords: آنتی بادی درمان; SCA; sÃndrome coronario agudo; SFA; stents farmacoactivos; SMSR; stents metálicos sin recubrimiento; TAPD; tratamiento antiagregante plaquetario combinado doble; Enfermedad coronaria; Stents farmacoactivos; Tratamiento antiagregante plaquetario; Coronar